precision tumor removal

Exvade is an oncology-focused company developing the Tumor Monorail Device, which uses bio-inspired cues to guide invasive brain tumor cells into a small, accessible reservoir where they can be safely removed and analyzed. The company is conducting a First-in-Human study of the device at the Preston Robert Tisch Brain Tumor Center at Duke University to evaluate its safety.

Read more

clinical trialsreal-time tissue analysistargeted drug delivery